6JG-25427-76304
3 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 201 / VA
- Registered
- 2022-02-07
- Relationship
- Self
- Race
- Native Hawaiian or other Pacific Islander
- Ethnicity
- N/A
Timeline
-
2021-01-28
Dose 1 — Pfizer-BioNTech
-
2021-02-23
Dose 2 — Pfizer-BioNTech
-
2022-01-13
Dose 3 — Pfizer-BioNTech
-
2022-02-07
Registered in v-safe
-
2022-02-15
Survey response — day 28, dose 3MedDRA: Headache, Nasopharyngitis, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: a headache . High temperature and sense of coldMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | No |
| 2 | 2021-02-23 | Pfizer-BioNTech | No |
| 3 | 2022-01-13 | Pfizer-BioNTech | No |
Free text
Release 11 — day 28, dose 3
Symptoms: a headache . High temperature and sense of cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release